Dow Up 0.36% Nasdaq Up 0.12%

Gilead Sciences Inc. (GILD)

-NasdaqGS
102.27 Up 1.48(1.47%) 4:00PM EDT
|After Hours : 102.01 Down 0.26 (0.25%) 7:23PM EDT - Nasdaq Real Time Price
Prev Close:100.79
Open:101.00
Bid:102.01 x 300
Ask:102.22 x 100
1y Target Est:111.43
Beta:1.01
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:100.86 - 102.31
52wk Range:58.50 - 102.57
Volume:9,796,275
Avg Vol (3m):11,573,400
Market Cap:154.60B
P/E (ttm):37.88
EPS (ttm):2.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDUp 1.47%154.60B
GSKDown 0.23%114.58B
PFEDown 0.24%182.74B
RHHBYDown 0.02%247.61B

Key Statistics

Forward P/E (1 yr):10.94
P/S (ttm):8.74
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.00
Quarterly EPS Est (Sep-14) :1.89
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.51

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback